Lo-Ti Tsao Selected Research

Lipopolysaccharides

9/2006

Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lo-Ti Tsao Research Topics

Disease

3	Neoplasms (Cancer) 01/2005 - 03/2002
1	Sepsis (Septicemia) 09/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2008
1	Acute Lung Injury 09/2006
1	Septic Shock (Toxic Shock Syndrome) 01/2003

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 09/2006 - 01/2003
1	Dinoprostone (PGE2)FDA Link 09/2009
1	imidazoleIBA 09/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2008
1	5- (4- acridin- 9- ylamino)phenyl- 5- methyl- 3- methylenedihydrofuran- 2- oneIBA 09/2006
1	LipopolysaccharidesIBA 09/2006
1	Peroxidase (Myeloperoxidase)IBA 09/2006
1	Peptides (Polypeptides)IBA 09/2006
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2006
1	dihydrochalconeIBA 01/2005
1	ChalconesIBA 01/2005
1	AldehydesIBA 01/2005
1	Aluminum Oxide (Sapphire)IBA 01/2005
1	BromidesIBA 01/2005
1	acetophenoneIBA 01/2005
1	AcetophenonesIBA 01/2005
1	AcridinesIBA 10/2002
1	justicidinsIBA 03/2002
1	diphyllinIBA 03/2002
1	tuberculatinIBA 03/2002